AKEBIA THERAPEUTICS, INC. Increase (Decrease) in Derivative Liabilities
AKEBIA THERAPEUTICS, INC. (AKBA) reported Increase (Decrease) in Derivative Liabilities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2026-02-26
- AKEBIA THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-12-31 was -$760.00K.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-09-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-06-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-03-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in derivative liabilities for fiscal 2025 was $0.00.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in derivative liabilities for fiscal 2024 was $0.00.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in derivative liabilities for fiscal 2023 was -$760.00K.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in derivative liabilities for fiscal 2022 was -$1.06M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2023-12-31 | -$760.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$760.00K derived: sum of 2 quarters · filed 2026-02-26 | -$760.00K derived: sum of 3 quarters · filed 2026-02-26 | -$760.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-03-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-28 | $0.00 10-Q · filed 2023-08-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | -$350.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | -$350.00K derived: sum of 3 quarters · filed 2024-03-14 | -$350.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$350.00K derived: sum of 2 quarters · filed 2024-03-14 | -$350.00K derived: sum of 3 quarters · filed 2024-03-14 | -$1.06M 10-K · filed 2024-03-14 |
| 2022-09-30 | -$350.00K 10-Q · filed 2022-11-03 | -$350.00K derived: sum of 2 quarters · filed 2022-11-03 | -$1.06M 10-Q · filed 2023-11-08 | -$1.17M derived: sum of 4 quarters · filed 2023-08-28 |
| 2022-06-30 | $0.00 10-Q · filed 2022-11-03 | -$710.00K 10-Q · filed 2023-08-28 | -$820.00K derived: sum of 3 quarters · filed 2023-08-28 | -$820.00K derived: sum of 4 quarters · filed 2023-08-28 |
| 2022-03-31 | -$710.00K 10-Q · filed 2023-05-08 | -$820.00K derived: sum of 2 quarters · filed 2023-08-28 | -$820.00K derived: sum of 3 quarters · filed 2023-08-28 | -$1.39M derived: sum of 4 quarters · filed 2023-08-28 |
| 2021-12-31 | -$110.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | -$110.00K derived: sum of 2 quarters · filed 2023-08-28 | -$680.00K derived: sum of 3 quarters · filed 2023-08-28 | -$600.00K 10-K/A · filed 2023-08-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 | -$570.00K derived: sum of 2 quarters · filed 2021-11-04 | -$490.00K 10-Q · filed 2022-11-03 | -$544.00K derived: sum of 4 quarters · filed 2023-08-28 |
| 2021-06-30 | -$570.00K 10-Q · filed 2021-11-04 | -$490.00K 10-Q · filed 2022-08-04 | -$544.00K derived: sum of 3 quarters · filed 2023-08-28 | -$444.00K derived: sum of 4 quarters · filed 2023-08-28 |
| 2021-03-31 | $80.00K 10-Q · filed 2022-05-09 | $26.00K derived: sum of 2 quarters · filed 2023-08-28 | $126.00K derived: sum of 3 quarters · filed 2023-08-28 | $276.00K derived: sum of 4 quarters · filed 2023-08-28 |
| 2020-12-31 | -$54.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | $46.00K derived: sum of 2 quarters · filed 2023-08-28 | $196.00K derived: sum of 3 quarters · filed 2023-08-28 | $286.00K 10-K/A · filed 2023-08-28 |
| 2020-09-30 | $100.00K 10-Q · filed 2020-11-05 | $250.00K derived: sum of 2 quarters · filed 2020-11-05 | $340.00K 10-Q · filed 2021-11-04 | $340.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $150.00K 10-Q · filed 2020-11-05 | $240.00K 10-Q · filed 2021-08-05 | $240.00K derived: sum of 3 quarters · filed 2022-03-01 | $240.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $90.00K 10-Q · filed 2021-05-10 | $90.00K derived: sum of 2 quarters · filed 2022-03-01 | $90.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |